Alerts will be sent to your verified email
Verify Email
EIKO
|
Eiko Lifesciences
|
Sunil Healthcare
|
Archit Organosys
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-13.22 % | 1.91 % | 13.11 % |
|
5yr average Equity Multiplier
|
1.89 | 2.47 | 1.91 |
|
5yr Average Asset Turnover Ratio
|
0.56 | 0.77 | 1.13 |
|
5yr Avg Net Profit Margin
|
-2.7 % | 0.33 % | 5.91 % |
|
Price to Book
|
1.53 | 1.27 | 1.4 |
|
P/E
|
49.73 | 412.98 | 17.91 |
|
5yr Avg Cash Conversion Cycle
|
142.89 Days | 113.61 Days | 21.62 Days |
|
Inventory Days
|
181.08 Days | 64.09 Days | 13.61 Days |
|
Days Receivable
|
132.25 Days | 139.61 Days | 96.08 Days |
|
Days Payable
|
199.48 Days | 139.86 Days | 66.01 Days |
|
5yr Average Interest Coverage Ratio
|
-0.92 | 1.69 | 4.41 |
|
5yr Avg ROCE
|
-87.29 % | 9.44 % | 15.36 % |
|
5yr Avg Operating Profit Margin
|
-7.02 % | 5.47 % | 10.79 % |
|
5 yr average Debt to Equity
|
0.23 | 0.9 | 0.51 |
|
5yr CAGR Net Profit
|
30.26 % | -18.44 % | -16.81 % |
|
5yr Average Return on Assets
|
-3.5 % | 1.18 % | 6.64 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
36.23 % | 73.53 % | 65.3 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
25.64 % | 0.0 | 7.9 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Eiko Lifesciences
|
Sunil Healthcare
|
Archit Organosys
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|